Thursday, May 17, 2012

Area child to travel to China for treatment

May 19, 2010 by biotechconnection.com · Leave a Comment 

Area child to travel to China for treatment
LEWISBURG — An innovative procedure in China may soon allow a little girl from Lewisburg to live a normal life despite being diagnosed with a condition that has no cure.
Read more on The Milton Standard-Journal

Lentigen Awarded Phase I STTR Grant for Hunter Syndrome

May 19, 2010 by biotechconnection.com · Leave a Comment 

Lentigen Awarded Phase I STTR Grant for Hunter Syndrome
Lentigen Corporation, a biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today that it has received a National Institutes of Health small business technology transfer grant for a program on “Lentiviral Gene Therapy for Mucopolysaccharidosis.”
Read more on PR Newswire via Yahoo! [...]

County council delays move to ban fireworks

May 19, 2010 by biotechconnection.com · Leave a Comment 

County council delays move to ban fireworks
A possible ban on fireworks in unincorporated Snohomish County has been postponed until at least 2012 after county councilmen opted Monday to spend more time studying a recent proposal.
Read more on Everett Herald

Voters receive one more look at school budget before election

May 19, 2010 by biotechconnection.com · Leave a Comment 

Voters receive one more look at school budget before election
Warwick – The public was given one last chance to review the school budget at this week’s regular monthly meeting of the Warwick Valley Central School Board.
Read more on The Warwick Advertiser

Market Publishers Ltd and BioInformant Worldwide Sign Partnership Agreement

May 19, 2010 by biotechconnection.com · Leave a Comment 

Market Publishers Ltd and BioInformant Worldwide Sign Partnership Agreement
LONDON—-Market Publishers ltd and BioInformant Worldwide signed partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorized to distribute and sale research reports by BioInformant Worldwide.
Read more on Business Wire via Yahoo! Finance

« Previous PageNext Page »